Skip to content
value.today
Maternova, Inc. logo

Maternova, Inc.

Total raised
$1 M
1 round on record
Latest round
$1 M
Mar 2022
First round on record
Mar 2022
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Maternova, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2022$1 MNo. 1Under $2 million

Maternova, Inc.: Raise no. 1, Mar 2022

Investors in this round

9 investors had bought by the notice of Sep 26, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Margaret Wirth · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Margaret Wirth, President. Source: SEC Form D, newest notice filed Sep 26, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Maternova, Inc. reported revenue of $345,907 for its fiscal year to 1 June 2021 (filed Jun 2021), down from $442,702 the year before.

    SEC Form C-AR · Jun 2021

  • The direct cost of what it sold was $233,497, so 32% of its revenue was left after those costs.

    SEC Form C-AR · Jun 2021

  • Net loss for the same year: $98,761.

    SEC Form C-AR · Jun 2021

  • Maternova, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).

    SEC Form D · Sep 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2023

In its own words

How the company describes itself to search engines on its website, word for word.

“Discover innovative maternal, reproductive, and neonatal health solutions. Trusted medical devices and diagnostics saving lives globally since 2015.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Maternova, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Maternova, Inc.
NameRoleNamed in
Margaret WirthExecutive officerSep 2023
Margaret WirthDirectorSep 2023